Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin

被引:98
作者
Deng, G [1 ]
Curriden, SA [1 ]
Hu, G [1 ]
Czekay, RP [1 ]
Loskutoff, DJ [1 ]
机构
[1] Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1002/jcp.1133
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Plasminogen activator inhibitor-1 (PAI-1) binds to the somatomedin B (SMB) domain of vitronectin. It inhibits the adhesion of U937 cells to vitronectin by competing with the urokinase receptor (uPAR; CD87) on these cells for binding to the same domain. Although the inhibitor also blocks integrin-mediated cell adhesion, the molecular basis of this effect is unclear. In this study, the effect of the inhibitor on the adhesion of a variety of cells (e.g., U937, MCF7, HT-1080, and HeLa) to vitronectin was assessed, and the importance of the SMB domain in these interactions was determined. Although PAI-1 blocked the adhesion of all of these cells to vitronectin-coated wells, it did not block adhesion to a variant of vitronectin which lacked the SMB domain. Interestingly, HT-1080 and U937 cells attached avidly to microtiter wells coated with purified recombinant SMB (which does not contain the RGD sequence), and this adhesion was again blocked by the inhibitor. These results affirm that PAI-1 can inhibit both uPAR- and integrin-mediated cell adhesion, and demonstrate that the SMB domain of vitronectin is required for these effects. They also show that multiple cell types can employ uPAR as an adhesion receptor. The use of purified recombinant SMB should help to further define this novel adhesive pathway, and to delineate its relationship with integrin-mediated adhesive events. J. Cell. Physiol. 189: 23-33, 2001. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:23 / 33
页数:11
相关论文
共 68 条
  • [31] HOWLETT AR, 1995, J CELL SCI, V108, P1945
  • [32] IMPLICATIONS OF THE 3-DIMENSIONAL STRUCTURE OF ALPHA-1-ANTITRYPSIN FOR STRUCTURE AND FUNCTION OF SERPINS
    HUBER, R
    CARRELL, RW
    [J]. BIOCHEMISTRY, 1989, 28 (23) : 8951 - 8966
  • [33] Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice
    Jang, YC
    Tsou, R
    Gibran, NS
    Isik, FF
    [J]. SURGERY, 2000, 127 (06) : 696 - 704
  • [34] Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation
    Kjoller, L
    Kanse, SM
    Kirkegaard, T
    Rodenburg, KW
    Ronne, E
    Goodman, SL
    Preissner, KT
    Ossowski, L
    Andreasen, PA
    [J]. EXPERIMENTAL CELL RESEARCH, 1997, 232 (02) : 420 - 429
  • [35] Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice
    Konstantinides, S
    Schäfer, K
    Thinnes, T
    Loskutoff, DJ
    [J]. CIRCULATION, 2001, 103 (04) : 576 - 583
  • [36] Truss optimization considering homologous deformation under multiple loadings
    Lee, KH
    Kim, KK
    Park, GJ
    [J]. STRUCTURAL OPTIMIZATION, 1998, 16 (2-3) : 193 - 200
  • [37] The adipocyte and hemostatic balance in obesity studies of PAI-1
    Loskutoff, DJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (01) : 1 - 6
  • [38] MIMURO J, 1989, J BIOL CHEM, V264, P936
  • [39] MIMURO J, 1989, J BIOL CHEM, V264, P5058
  • [40] NASKI MC, 1993, J BIOL CHEM, V268, P12367